Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF versus growth hormone in poor ovarian responders undergoing IVF
IRCT20110509006420N29Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in female infertility and poor ovarian response (POR) comparing G-CSF + antagonist protocol IVF with Growth hormone + antagonist protocol IVF (2 arms). Primary endpoints: Number of retrieved oocytes, Number of MII oocytes and 7 more. Started May 2025; status: completed.
02
Drugs
granulocyte colony-stimulating factorsomatropin
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20110509006420N29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110509006420N29.